Quick Answer
AVAI BIO, INC. reported Cash and Equivalents of $81.1 thousand for fiscal year 2025.
AVAI BIO, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $81.1K | +28744.5% |
| 2024 | $281.00 | -99.7% |
| 2023 | $107.5K | +222.8% |
| 2022 | $33.3K | -44.9% |
| 2021 | $60.4K | +121.1% |
| 2020 | $27.3K | +0.0% |
| 2020 | $27.3K | +26665.7% |
| 2019 | $102.00 | -98.2% |
| 2018 | $5.7K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $50.4K | +1541.8% | -45.2% |
| September 30, 2025 | $92.0K | +5091.6% | +814.3% |
| June 30, 2025 | $10.1K | +2166.2% | -87.6% |
| March 31, 2025 | $81.1K | +28744.5% | +2540.2% |
| December 31, 2024 | $3.1K | +242.6% | +73.3% |
| September 30, 2024 | $1.8K | +19.7% | +299.1% |
| June 30, 2024 | $444.00 | -14.3% | +58.0% |
| March 31, 2024 | $281.00 | -99.7% | -68.6% |
- AVAI BIO, INC. showed an increase of +28744.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, AVAI BIO, INC.’s cash and equivalents has grown by 1324.2% (from $5.7 thousand to $81.1 thousand).
- The most recent figure is from AVAI BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: